HDFC Life Insurance reported a 9% year-on-year rise in value of new business to ₹880 crore for the first quarter of fiscal 2027. Despite a slight margin compression due to regulatory impacts, the company maintained a 25% VNB margin supported by a shift toward annuity products. Investors are monitoring the recovery of its bancassurance channel, which saw flat growth during the quarter.
HDFC Life Insurance Company Limited reported its financial results for the first quarter of the 2027 fiscal year, showing consistent growth despite a challenging high-base effect. The insurer recorded a value of new business (VNB) of ₹880 crore, representing a 9% increase compared to the same period last year. Annual premium equivalent (APE), a key metric for measuring insurance sales, also rose by 9% to ₹3,520 crore.
Margin Dynamics and Product Mix
The company’s VNB margin stood at 25%, marking a marginal 10 basis point decline year-on-year. This slight contraction was attributed to several factors, including the impact of Goods and Services Tax (GST) adjustments and changes in actuarial assumptions. Negative operating leverage also played a role in the dip. However, these pressures were largely mitigated by an improved product mix. The company saw a strategic move toward higher-value products, with unit-linked insurance plans (ULIPs) now making up 44% of total APE, compared to 38% in the previous year. Furthermore, the share of annuity products doubled to 11%, aided by the launch of a new variable annuity offering, while retail protection saw a 42% increase.
Channel Performance and Strategic Outlook
A notable highlight of the quarter was the growth in non-HDFC Bank channels, which expanded by 17% collectively. The agency channel, in particular, grew by 21%, with new branches opened in the last two years beginning to drive sales. Conversely, the bancassurance segment, which relies heavily on HDFC Bank, remained flat on a year-on-year basis. Management has characterized the softness in the HDFC Bank channel as a cyclical trend and remains optimistic about returning to mid-teens growth in the coming quarters. The company’s solvency ratio rose to 185% following a recent capital infusion, providing a stable foundation for the next 15 to 18 months.
Operational Metrics and Next Steps
Operational efficiency and persistency remain key focus areas for the insurer. The 13-month persistency ratio moderated slightly to 84%, influenced by changes in the tax environment for certain products, while the 61-month persistency ratio saw an improvement to 65%. Embedded value grew by 13% year-on-year to ₹65,860 crore, reflecting a healthy operating return on embedded value of 14.7%. Moving forward, investors will be closely tracking the performance of the bancassurance channel to see if it regains momentum, as well as the company’s ability to sustain its 25% VNB margin targets amidst potential shifts toward a risk-based capital regime.